换一批
换一批Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal.
作者：
David,Tamborero [1]
;
Rodrigo,Dienstmann [2]
;
Maan Haj,Rachid [3]
;
Jorrit,Boekel [3]
;
Richard,Baird [4]
;
Irene,Braña [5]
;
Luigi,De Petris [6]
;
Jeffrey,Yachnin [7]
;
Christophe,Massard [6]
;
Frans L,Opdam [7]
;
Richard,Schlenk [8]
;
Claudio,Vernieri [9]
;
Elena,Garralda [10]
;
Michele,Masucci [11]
;
Xenia,Villalobos [12]
;
Elena,Chavarria [5]
;
Cancer Core Europe consortium [13]
;
Fabien,Calvo [14]
;
Stefan,Fröhling [14]
;
Alexander,Eggermont [15]
;
Giovanni,Apolone [16]
;
Emile E,Voest [17]
;
Carlos,Caldas [18]
;
Josep,Tabernero [19]
;
Ingemar,Ernberg [20]
;
Jordi,Rodon [21]
;
Janne,Lehtiö [4]
作者单位：
Department of Oncology and Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden. david.tamborero@ki.se.
[1]
Medical Oncology-Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
[2]
Department of Oncology and Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
[3]
Cancer Research UK Cambridge Centre, Cambridge, UK.
[4]
Medical Oncology Department, Vall d'Hebron Institute of Oncology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
[5]
Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
[6]
Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
[7]
Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
[8]
Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
[9]
NCT Trial Center, German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany.
[10]
Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
[11]
IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy.
[12]
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
[13]
Research Coordination Area, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
[14]
Gustave Roussy Cancer Campus Grand Paris, Villejuif, France Cancer Core Europe, Villejuif, France.
[15]
Division of Translational Medical Oncology, National Center for Tumor Diseases Heidelberg and German Cancer Research Center, Heidelberg, Germany.
[16]
German Cancer Consortium, Heidelberg, Germany.
[17]
Scientific Directorate, Princess Máxima Center, Utrecht, the Netherlands.
[18]
Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
[19]
Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
[20]
Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
[21]
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, UVic-UCC, Barcelona, Spain.
[22]
Investigational Cancer Therapeutics Department, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[23]
Department of Oncology and Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden. janne.lehtio@ki.se.
[24]
DOI
10.1038/s41591-020-0969-2
PMID
32632195
发布时间
2024-02-10
- 浏览0
Nature medicine
Nature medicine
992-994页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
